Abstract
Background: Low sexual desire is present in 1/3 of male-to-female transsexuals (post-operative male-to-female transsexual persons on estrogen replacement). Several studies report lower endogenous testosterone (T) levels in this group compared to community dwelling women. However, no relationship between T and sexual desire has been found in male-to-female transsexuals. Considering its role in androgen sensitivity, cytosine-adenine-guanine (CAG) trinucleotide repeat sequence in the androgen receptor (AR) might modify the relationship between T levels and sexual desire in male-to-female transsexuals. Aim: This study aims to assess the potential contribution of the number of CAG repeats in the association between T and sexual desire in male-to-female transsexuals. Material, subjects, and methods: Thirty-four post-operative male-to-female transsexuals participated in a cross-sectional study. The Sexual Desire Inventory, a questionnaire measuring sexual desire, was completed. Serum levels of total (TT) and free T (FT), DHEA-S, SHBG, and LH were measured in morning blood samples. AR gene CAG repeat length was determined by automated DNA fragment analysis of exon 1 of the AR gene. Results: The CAG repeat length ranged from 14 to 28 with a median of 21. CAG polymorphism was correlated with FT (r=0.389; p=0.023) but not with TT (r=0.191; p=0.280). The observed interaction between TT and CAG was significant only for solitary sexual desire (p=0.002). The interaction of CAG repeats and FT on sexual desire failed to reach significance. Conclusions: We could not establish that CAG repeat length is a consistent modulating factor in the relationship between TT or FT and sexual desire in male-to-female transsexuals.
Similar content being viewed by others
References
Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006, 91: 3697–710.
Wierman ME, Basson R, Davis SR, et al. Are the endocrine society’s clinical practice guidelines on androgen therapy in women misguided? A commentary-response. J Sex Med 2007, 4: 1782–3.
Traish A, Guay AT, Spark RF; Testosterone Therapy in Women Study Group. Are the endocrine society’s study’s clinical practice guidelines on androgen therapy misguided? A commentary. J Sex Med 2007, 4: 1223–35.
Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005, 294: 91–6.
Turna B, Apaydin E, Semerci B, Altay B, Cikili N, Nazli O. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Impot Res 2005, 17: 148–53.
Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the Study of Women’s Health Across the Nation. J Clin Endocrinol Metab 2005, 90: 4836–45.
Elaut E, De Cuypere G, De Sutter P, et al. Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels. Eur J Endocrinol 2008, 158: 393–9.
De Cuypere G, T’Sjoen G, Beerten R, et al. Sexual and physical health after sex reassignment surgery. Arch Sexual Behav 2005, 34: 679–90.
Crabbe P, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab 2007, 92: 3604–10.
Albertelli MA, Scheller A, Brogley M, Robins DM. Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 2006, 20: 1248–60.
Brown CJ, Goss SJ, Lubahn DB, et al. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 1989, 44: 264–9.
Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992, 12: 241–53.
Henningsson S, Westberg L, Nilsson S,et al. Sex steroid-related genes and male-to-female transsexualism. Psychoneuroendocrinology 2005, 30: 657–64.
Hare L, Bernard P, Sánchez FJ, et al. Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biol Psychiatry 2009, 65: 93–6.
Spector IP, Carey MP, Steinberg L. The sexual desire inventory: development, factor structure, and evidence of reliability. J Sex Marital Ther 1996, 22: 175–90.
Vermeulen A, Verdonck L. Radioimmunoassay of 17β-hydroxy-5α-androstan-3-one, 4-androstene-3, 17-dione, dehydroepiandrosterone, 17-hydroxyprogesterone and progesterone and its application to human male plasma. J Steroid Biochem 1976, 7: 1–10.
Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf) 1978, 9: 407–12.
Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84: 3666–72.
Laughlin GA, Barret-Conner E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo study. J Clin Endocrinol Metab 2000, 85: 645–51.
Randolph JF Jr, Sowers M, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003, 88: 1516–22.
Vermeulen A, Goemaere S, Kaufman JM. Sex hormones, body composition and aging. Aging Male 1999, 2: 8–15.
Whalen RE. Sexual motivation. Psychol Rev 1966, 73: 151–63.
Corona G, Petrone L, Mannucci E, et al. The impotent couple: low desire. Int J Androl 2005, 28(Suppl 2): 46–52.
Author information
Authors and Affiliations
Corresponding author
Additional information
E. Elaut and V. Bogaert contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Elaut, E., Bogaert, V., De Cuypere, G. et al. Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: An exploration in male-to-female transsexuals. J Endocrinol Invest 33, 37–41 (2010). https://doi.org/10.1007/BF03346547
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346547